Literature DB >> 9890848

Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series.

J D Rich1, N A Merriman, E Mylonakis, T C Greenough, T P Flanigan, B J Mady, C C Carpenter.   

Abstract

BACKGROUND: The availability of sensitive assays for plasma HIV viral load and the trend toward earlier and more aggressive treatment of HIV infection has led to the inappropriate use of these assays as primary tools for the diagnosis of acute HIV infection.
OBJECTIVE: To describe limitations in the use of plasma viral load testing for the diagnosis of HIV infection.
DESIGN: Case series.
SETTING: Academic medical centers in Providence, Rhode Island, and Worcester, Massachusetts. PATIENTS: Three persons in whom HIV infection was falsely diagnosed by plasma viral load testing. MEASUREMENTS: Laboratory measures and clinical outcomes.
RESULTS: Two cases of false-positive results obtained by using branched-chain DNA plasma viral load assays and one case of a false-positive result obtained by using reverse transcriptase-polymerase chain reaction plasma viral load assay are reported. All three plasma viral load tests yielded positive results with low values (1254 copies/mL, 1574 copies/mL, and 1300 copies/mL). Infection with HIV was initially diagnosed in all three patients, but each patient subsequently tested negative by HIV-1 enzyme-linked immunosorbent assay and repeated plasma viral load testing.
CONCLUSION: Physicians should exercise caution when using plasma viral load assays to detect primary HIV infection, particularly when the pretest probability of infection is low.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890848     DOI: 10.7326/0003-4819-130-1-199901050-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  False-positive result from a Bayer Versant human immunodeficiency virus type 1 branched-DNA viral load assay, with a possible role for light leakage after inadequate maintenance of the analyzer.

Authors:  Adrian Marinovich; Momka Narlieva; Mohammed Bashir; Barry S Zingman; Amy Fox
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

Review 2.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

3.  Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0.

Authors:  J A Kellogg; P V Atria; J C Sanders; M E Eyster
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  Testing for HIV infection in the United States.

Authors:  Lindsey L Wolf; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

5.  Cost-effectiveness of nucleic acid amplification tests for identifying acute HIV infections.

Authors:  Jean Maritz; Wolfgang Preiser
Journal:  J Clin Microbiol       Date:  2011-04       Impact factor: 5.948

6.  HIV exceptionalism, CD4+ cell testing, and conscientious subversion.

Authors:  L A Jansen
Journal:  J Med Ethics       Date:  2005-06       Impact factor: 2.903

7.  Use of plastic vacutainer tubes for quantification of human immunodeficiency virus type 1 in blood specimens.

Authors:  M L Landry; R Garner; D Ferguson
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  A Erice; D Brambilla; J Bremer; J B Jackson; R Kokka; B Yen-Lieberman; R W Coombs
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 9.  Should we treat acute HIV infection?

Authors:  Meagan O'Brien; Martin Markowitz
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

10.  Multicenter evaluation of the performance characteristics of the NucliSens HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA.

Authors:  Christine C Ginocchio; Marti Kemper; Kathleen A Stellrecht; Donald J Witt
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.